«

»

StockReports.net Weekly Penny Stocks Wrap-up and Commentary on SunPeaks Ventures, Stevia First Corp, Beneficial Holdings, Arena Pharmaceuticals and Muscle Pharm Corp

StockReports.net Weekly Penny Stocks Wrap-up and Commentary on SunPeaks Ventures, Stevia First Corp, Beneficial Holdings, Arena Pharmaceuticals and Muscle Pharm Corp











StockReports.net Free Trend Analysis Reports

New York, NY (PRWEB) March 31, 2012

Several Watch List Picks from this week have shown considerable gains as well as trading opportunities for investors and day traders alike.

SunPeaks Ventures has become regular on this Watch List as well as StockReports.net SMS Alert. Initially profiled while trading at $ 0.40 to StockReports.net members, SunPeaks Ventures now traded as high $ 1.04 yesterday before an expected retraction occurred today sending the shares down almost 25%.

Yet SunPeaks Ventures stands as one of the most profitable and most liquid trading opportunities presented to StockReports.net members in March 2012.

Most recently SunPeaks Ventures recently announced the availability of its product Clotamin in WallGreens.com as well as several other major outlets such as Navarro’s

Many Investors are asking if it is too late to ride the SunPeaks Ventures momentum.

Get the Full Report here: http://www.StockReports.net/stocks/SNPK

Stevia First Corp was on alert last week when trading in the $ 1.25 range. Strong volume and investor interest pushed the shares to close near $ 1.50.

However, this week seems to have been considerable more profitable as shares of Stevia First Corp hit a high and closed at $ 3.24 on Wednesday.

After a 50% retraction on Thursday, shares of Stevia First Corp gained another 10% today showing a potential strength in the shares and a continued momentum.

Stevia First Corp has been showing several such opportunities for traders to enter trades during dips and potential profits occurred several times these last two weeks.

A Quick look at the Chart of Stevia First Corp shows many such occurrences. Investors are asking if there will be another opportunity to successfully trade shares of Stevia First Corp, Read StockReports.net’s Trend Analysis.

Get the Full Report here : http://www.StockReports.net/stocks/STVF

A New Player on StockReports.net’s Watchlist is Beneficial Holdings Inc. The Company just recently announced they would be applying for a Nevada Interstate Gaming License which will enable it, partnered with a licensed casino operator, to offer certain online games.

With a license under Nevada Regulations 5A, the company may be able to offer non-gaming hotels access to the online casino in customer rooms.

Shares of Beneficial Holdings have gained tremendously two days in a row seeing gains of 50% and 100% for Thursday and Friday respectively and trading as much as 240 Million Shares today.

Penny Stocks Trading in the $ 0.0004 range are often known to have the most explosive moves and the most volatile momentums.

Find Out Which Direction Could the Shares of Beneficial Holdings Take Next Week.

Get the Full Report here: http://www.StockReports.net/stocks/BFHJ

Muscle Pharm Corp. has had an amazing week starting at $ 0.145 and going as high as $ 0.358 representing a gain of as much as 238%.

The last two days have seen mostly sideways trading as the shares of Muscle Pharm Corp. have remained in the range of $ 0.035 potentially indicating consolidation and well as the psychological resistance level of $ 0.04.

Muscle Pharm Corp. most recently released many news that could have propelled the company’s shares to these recent highs.

Muscle Pharm Corp, announced that beginning April, 2012, Eurpac Service, Inc. (Eurpac), the primary distributor of consumer products to U.S. military exchanges, U.S. Navy ships and veteran’s canteen services located worldwide will begin distributing the award-winning Muscle Pharm product line.

What’s in Store Next Week for Muscle Pharm? Will the momentum resume?

Get the Full Report here: http://www.StockReports.net/stocks/MSLP

Biotech Penny Stocks seem very hot in 2012 and several have made the StockReports.net Watchlist. Among them is Arena Pharmaceuticals.

Initially alerted on this very watchlist on March 20th, Arena Pharmaceuticals was trading below $ 2. The Continued momentum as well as a consistent flow of news has pushed shares upwards of $ 3.20 in less than two weeks.

While two thirds of Americans are overweight, according to the Centers for Disease Control and Prevention more than one-third of U.S. adults (35.7%) are clinically obese.

The eventual application of Arena Pharmaceutical’s novel drug Lorcaserin is not only obesity. According to an article published in the Journal of Pharmacology and Experimental Therapeutics on 6/2/2011 Lorcaserin showed efficacy in decreasing nicotine use.

Find Out How Strong the Current Uptrend of Arena Pharmaceuticals is by subscribing to the Free Trend Analysis Report.

Arena Pharmaceuticals Report: http://www.StockReports.net/stocks/ARNA

About StockReports.net

StockReports.net is a full-service Financial Communications and Investor Relations Firm that specializes in maximizing investor awareness for micro-cap publicly traded companies.

StockReports.net issues momentum alerts on stocks that can provide gains to day traders.

StockReports.net provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% – 200% or more.

StockReports.net monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals, StockReports.net is often in the know of several large investor awareness campaigns being deployed.

Timing is everything when trading Penny Stocks. Gain an edge by joining the StockReport.net newsletter and receiving alerts from a Pro-Active team of researchers.

Stock Reports believes traders should have a chance at successfully trading Penny Stocks and invites traders and investors you to be part of the Free VIP membership.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: StockReports.net

Disclosure: StockReports.net is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. StockReports.net is a wholly owned entity of a financial public relations firm. We have not been compensated by any of these companies for this release. Please read our report and visit our website, for complete risks and disclosures.









Attachments





















Vocus©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.







Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>